Showing 20 of 173 recruiting trials for “squamous-cell-carcinoma-of-the-hypopharynx”
Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
RecruitingNCT06169163 ↗
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma
👨⚕️ Jian Guan, MD, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2023View details ↗
A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma
👨⚕️ Ying Wang, Ph.D, M.D., Chongqing University Cancer Hospital📍 1 site📅 Started Oct 2023View details ↗
A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 1 site📅 Started Sep 2023View details ↗
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
👨⚕️ Changqing Pan, the International Committee of Medical Journal Editors📍 1 site📅 Started Sep 2023View details ↗
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
👨⚕️ zhenyu ding, MD, West China Hospital, Sichuan University, China📍 1 site📅 Started Aug 2023View details ↗
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
🏥 Affiliated Cancer Hospital of Shantou University Medical College📍 1 site📅 Started Aug 2023View details ↗
A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies
Metastatic Nasopharyngeal Carcinoma
PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC
👨⚕️ Yu Weiwei, Department of Radiation Oncology, Affiliated Hospital of Nantong University📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT05833594 ↗
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
RecruitingNCT05894369 ↗
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →